Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.
<h4>Aims</h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin converting enzyme 2 (ACE2) enabling entrance of the virus into cells and causing the infection termed coronavirus disease of 2019 (COVID-19). Here, we investigate associations between plasma AC...
Main Authors: | Tue W Kragstrup, Helene Søgaard Singh, Ida Grundberg, Ane Langkilde-Lauesen Nielsen, Felice Rivellese, Arnav Mehta, Marcia B Goldberg, Michael R Filbin, Per Qvist, Bo Martin Bibby |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0252799 |
Similar Items
-
The Changes of Plasma MMPs/TIMPs and ACE/ACE2 Activity Ratios in Uremic Patients and during Hemodialysis
by: Lu, Li-Che, et al.
Published: (2016) -
IT Project Failures, Causes and Cures
by: Soren Lauesen
Published: (2020-01-01) -
ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study
by: Dipender Gill, et al.
Published: (2020-11-01) -
Genotyping and Mutation Detection In Situ : Development and application of single-molecule techniques
by: Grundberg, Ida
Published: (2011) -
MicroRNA-132 is a Physiological Regulator of Hematopoietic Stem Cell Function and B-cell Development
by: Mehta, Arnav
Published: (2015)